Parkinson's disease and other alpha-synucleinopathies
- PMID: 11388653
- DOI: 10.1515/CCLM.2001.047
Parkinson's disease and other alpha-synucleinopathies
Abstract
Parkinson's disease is the most common movement disorder and the second most common neurodegenerative disease. Neuropathologically, it is characterized by the degeneration of nerve cells that develop filamentous inclusions in the form of Lewy bodies and Lewy neurites. Recent work has shown that rare, familial forms of Parkinson's disease are caused by missense mutations in the alpha-synuclein gene and that the filamentous lesions of Parkinson's disease are made of alpha-synuclein. The same is true of the Lewy body pathology that is associated with other neurodegenerative diseases, such as dementia with Lewy bodies. The filamentous inclusions of multiple system atrophy have also been found to be made of alpha-synuclein, thus providing an unexpected molecular link with Lewy body diseases. Recombinant alpha-synuclein assembles into filaments with similar morphologies to those found in the human diseases and with a cross-beta diffraction pattern characteristic of amyloid. The related proteins beta-synuclein and gamma-synuclein are poor at assembling into filaments. They are not present in the pathological filamentous lesions and have not been found to be linked to genetic disease. The new work has established the alpha-synucleinopathies as a major class of neurodegenerative disease.
Similar articles
-
The alpha-synucleinopathies: Parkinson's disease, dementia with Lewy bodies, and multiple system atrophy.Ann N Y Acad Sci. 2000;920:16-27. doi: 10.1111/j.1749-6632.2000.tb06900.x. Ann N Y Acad Sci. 2000. PMID: 11193145 Review.
-
Filamentous nerve cell inclusions in neurodegenerative diseases: tauopathies and alpha-synucleinopathies.Philos Trans R Soc Lond B Biol Sci. 1999 Jun 29;354(1386):1101-18. doi: 10.1098/rstb.1999.0466. Philos Trans R Soc Lond B Biol Sci. 1999. PMID: 10434313 Free PMC article. Review.
-
Filamentous alpha-synuclein inclusions link multiple system atrophy with Parkinson's disease and dementia with Lewy bodies.Neurosci Lett. 1998 Jul 31;251(3):205-8. doi: 10.1016/s0304-3940(98)00504-7. Neurosci Lett. 1998. PMID: 9726379
-
A Drosophila model of Parkinson's disease.Nature. 2000 Mar 23;404(6776):394-8. doi: 10.1038/35006074. Nature. 2000. PMID: 10746727
-
Neuropathological spectrum of synucleinopathies.Mov Disord. 2003 Sep;18 Suppl 6:S2-12. doi: 10.1002/mds.10557. Mov Disord. 2003. PMID: 14502650 Review.
Cited by
-
Proteome analysis of human substantia nigra in Parkinson's disease.Proteome Sci. 2008 Feb 14;6:8. doi: 10.1186/1477-5956-6-8. Proteome Sci. 2008. PMID: 18275612 Free PMC article.
-
Structures of Pathological and Functional Amyloids and Prions, a Solid-State NMR Perspective.Front Mol Neurosci. 2021 Jul 1;14:670513. doi: 10.3389/fnmol.2021.670513. eCollection 2021. Front Mol Neurosci. 2021. PMID: 34276304 Free PMC article. Review.
-
Crosstalk between astrocytes and microglia results in increased degradation of α-synuclein and amyloid-β aggregates.J Neuroinflammation. 2021 Jun 3;18(1):124. doi: 10.1186/s12974-021-02158-3. J Neuroinflammation. 2021. PMID: 34082772 Free PMC article.
-
Polycation-induced oligomerization and accelerated fibrillation of human alpha-synuclein in vitro.Protein Sci. 2003 Apr;12(4):702-7. doi: 10.1110/ps.0230903. Protein Sci. 2003. PMID: 12649428 Free PMC article.
-
Protein disorder in the human diseasome: unfoldomics of human genetic diseases.BMC Genomics. 2009 Jul 7;10 Suppl 1(Suppl 1):S12. doi: 10.1186/1471-2164-10-S1-S12. BMC Genomics. 2009. PMID: 19594871 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous